Interstitial Lung Disease (ILD)

Advanced Diagnosis & Comprehensive Treatment at Metro Centre for Respiratory Diseases

Noida | Delhi NCR | India

Introduction

Interstitial Lung Disease (ILD) refers to a group of lung disorders characterized by inflammation, thickening, or scarring (fibrosis) of the lung interstitium. The interstitium is a delicate, lace-like tissue that supports the alveoli—microscopic air sacs responsible for oxygen exchange.

This network contains tiny blood vessels that allow oxygen to pass into the bloodstream and carbon dioxide to be removed. Under normal conditions, the interstitium is extremely thin and not visible on chest X-rays or CT scans. In ILD, inflammation or scarring causes this tissue to thicken, leading to reduced lung capacity, breathlessness, and impaired oxygen transfer.

Importance of Early Diagnosis

ILD may progress gradually and can cause irreversible lung damage if not diagnosed early. Patients often experience recurrent hospitalizations due to respiratory complications, which are associated with increased health risks.

At Metro Centre for Respiratory Diseases, early and accurate diagnosis is a priority to prevent disease progression and respiratory failure.

Expert Respiratory Care at Metro Hospital

Metro Centre for Respiratory Diseases is an advanced respiratory care centre in Noida and Delhi NCR, offering comprehensive diagnosis and treatment for complex lung conditions, including:

• Interstitial Lung Disease (ILD)
• Asthma
• Chronic Bronchitis
• Emphysema (COPD)
• Complicated chest infections
• Lung cancer

Our experienced pulmonologists use evidence-based protocols and advanced technology to deliver personalized care.

Diagnosis & Treatment Approach

ILD treatment is individualized based on:

• Type and cause of ILD
• Disease severity
• Rate of progression
• Overall patient health

Treatment Goals

• Reduce lung inflammation
• Prevent or slow further scarring
• Treat the underlying cause
• Manage complications
• Preserve lung function
• Improve quality of life

Medication Management

Medications aim to improve breathing, reduce inflammation, and regulate abnormal immune responses.

Common Treatment Options

• Anti-inflammatory medications
• Immunosuppressive therapy (for autoimmune-related ILD)
• Anti-fibrotic drugs

For idiopathic pulmonary fibrosis (IPF), FDA-approved medications include:

• Ofev (Nintedanib)
• Esbriet (Pirfenidone)

Avoiding environmental or occupational triggers is also a key part of disease management.

Oxygen Therapy

ILD can reduce oxygen levels in the blood. Depending on severity:

• Some patients require continuous oxygen therapy
• Others need oxygen during physical activity or sleep

Benefits include:

• Reduced breathlessness and fatigue
• Less strain on the heart and lungs
• Improved oxygen delivery to vital organs

Pulmonary Rehabilitation

Metro Hospital offers a structured pulmonary rehabilitation program that includes:

• Patient education
• Breathing techniques
• Supervised exercise training
• Energy conservation strategies
• Nutritional guidance
• Respiratory therapy assessment
• Psychological and social support

This program helps patients maintain independence and improve daily functioning.

Lung Transplantation

In advanced ILD cases with irreversible lung damage, lung transplantation may be considered. For selected patients, modern surgical techniques and specialized post-transplant care can significantly improve survival and quality of life.

Recovery & Long-Term Outlook

Response to treatment varies among patients. Some forms of ILD stabilize with therapy, while others may progress despite treatment.

Treatment is considered successful when it:

• Stabilizes symptoms
• Maintains lung function
• Prevents radiological progression

Regular follow-up and monitoring are essential for long-term disease control.

Frequently Asked Questions (FAQs)

1. What are the early symptoms of ILD?

Shortness of breath on exertion, persistent dry cough, fatigue, and reduced exercise tolerance are common early symptoms.

2. Is ILD curable?

Some forms are manageable and treatable. Fibrotic ILDs are usually not curable, but early treatment can slow progression.

3. How is ILD diagnosed?

Diagnosis may include pulmonary function tests, HRCT chest scans, blood tests, bronchoscopy, or lung biopsy.

4. Can ILD worsen over time?

Yes. Without treatment, ILD can progress and lead to respiratory failure.

5. Will I need oxygen therapy permanently?

Not always. Oxygen needs depend on disease severity and may change over time.

6. Is pulmonary rehabilitation necessary?

Yes. It improves breathing efficiency, stamina, and overall quality of life.

7. Why is Metro Centre for Respiratory Diseases considered an advanced lung care centre in Noida and Delhi NCR?

The centre offers advanced diagnostics, modern ICUs, experienced pulmonologists, and comprehensive respiratory care under one roof.

8. Do you provide advanced diagnostic facilities for ILD?

Yes. Facilities include HRCT, PFTs, bronchoscopy, laboratory testing, and multidisciplinary evaluation.

9. Is multidisciplinary care available for ILD patients?

Yes. Care involves pulmonologists, radiologists, pathologists, rheumatologists, respiratory therapists, and rehabilitation experts.

10. Do patients from Delhi NCR and nearby regions visit Metro Hospital for lung care?

Yes. Patients from Noida, Greater Noida, Ghaziabad, Delhi, Faridabad, and North India seek advanced respiratory treatment here.

11. Are ICU and emergency services available for severe respiratory conditions?

Yes. The hospital has fully equipped respiratory ICUs and 24/7 emergency support.

12. Why should patients choose Metro Centre for Respiratory Diseases?

Because of expert doctors, advanced technology, patient-centric care, structured rehabilitation, and proven outcomes in respiratory medicine.